Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morton Scheinberg

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Nature Clinical Practice. Rheumatology|February 7, 2008
Why do some biologic agents induce psoriasis or psoriasiform lesions?Ieda Mm Laurindo, Morton Scheinberg
Nature Reviews. Rheumatology|April 16, 2016
Therapy: The NICE position on indications for biologics and biosimilarsMorton Scheinberg, Juan J Gomez-Reino
Annals of the Rheumatic Diseases|May 9, 2020
Steroid-resistant sarcoidosis treated with baricitinibMorton Scheinberg, Fernando Maluf, Jairo Wagner
Clinical Rheumatology|December 19, 2007
Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative associationLuiz Sergio Guedes-Barbosa, Cristovão Mangueira, Morton Scheinberg
Clinical Rheumatology|May 20, 2020
Full histological and clinical regression of morphea with tofacitinibMorton Scheinberg, Cid Sabbagh, Sineida Ferreira, et al.
Rheumatology (Oxford, England)|January 27, 2010
The effect of tocilizumab on the uptake of 18FDG-PET imaging in patients with adult-onset Still's diseaseMarcelo L Cunha, Jairo Wagner, Akemi Osawa, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 9, 2008
Anti-TNF agents inducing psoriasis: a recognized adverse effectMorton Scheinberg, Deborah Pereira Gonçalves, Iêda M M Laurindo
Revista Brasileira De Reumatologia|July 24, 2014
When anti-TNF fails, anti-IL12-23 is an alternate option in psoriasis and psoriatic arthritisRicardo Prado Golmia, Ayk Helena Barbosa Martins, Morton Scheinberg
The Journal of Rheumatology|October 3, 2012
Failure to control progression of rheumatoid arthritis after a decade of biologic therapyMorton Scheinberg, Renee Zon Filippi, Rebbeca Hands, et al.
Clinical Rheumatology|May 9, 2008
Retrospective study evaluating dose standards for infliximab in patients with rheumatoid arthritis at Hospital Israelita Albert Einstein, São Paulo, BrazilMorton Scheinberg, José Goldenberg, Daniel P Feldman, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Nature Clinical Practice. Rheumatology|February 7, 2008
Why do some biologic agents induce psoriasis or psoriasiform lesions?Ieda Mm Laurindo, Morton Scheinberg
Nature Reviews. Rheumatology|April 16, 2016
Therapy: The NICE position on indications for biologics and biosimilarsMorton Scheinberg, Juan J Gomez-Reino
Annals of the Rheumatic Diseases|May 9, 2020
Steroid-resistant sarcoidosis treated with baricitinibMorton Scheinberg, Fernando Maluf, Jairo Wagner
Clinical Rheumatology|December 19, 2007
Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative associationLuiz Sergio Guedes-Barbosa, Cristovão Mangueira, Morton Scheinberg
Clinical Rheumatology|May 20, 2020
Full histological and clinical regression of morphea with tofacitinibMorton Scheinberg, Cid Sabbagh, Sineida Ferreira, et al.
Rheumatology (Oxford, England)|January 27, 2010
The effect of tocilizumab on the uptake of 18FDG-PET imaging in patients with adult-onset Still's diseaseMarcelo L Cunha, Jairo Wagner, Akemi Osawa, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 9, 2008
Anti-TNF agents inducing psoriasis: a recognized adverse effectMorton Scheinberg, Deborah Pereira Gonçalves, Iêda M M Laurindo
Revista Brasileira De Reumatologia|July 24, 2014
When anti-TNF fails, anti-IL12-23 is an alternate option in psoriasis and psoriatic arthritisRicardo Prado Golmia, Ayk Helena Barbosa Martins, Morton Scheinberg
The Journal of Rheumatology|October 3, 2012
Failure to control progression of rheumatoid arthritis after a decade of biologic therapyMorton Scheinberg, Renee Zon Filippi, Rebbeca Hands, et al.
Clinical Rheumatology|May 9, 2008
Retrospective study evaluating dose standards for infliximab in patients with rheumatoid arthritis at Hospital Israelita Albert Einstein, São Paulo, BrazilMorton Scheinberg, José Goldenberg, Daniel P Feldman, et al.
Pageof 7